Szot Matthew K 4
4 · Cadrenal Therapeutics, Inc. · Filed Oct 28, 2025
Insider Transaction Report
Form 4
Szot Matthew K
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-10-24$13.99/sh−1,800$25,182→ 11,733 total - Sale
Common Stock
2025-10-27$13.99/sh−1,800$25,182→ 9,933 total
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on May 9, 2025.